Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60,099 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
Zheng CH, Yang H, Zhang M, Lu SH, Shi D, Wang J, Chen XH, Ren XH, Liu J, Lv JG, Zhu J, Zhou YJ. Zheng CH, et al. Among authors: yang h. Bioorg Med Chem Lett. 2012 Jan 1;22(1):39-44. doi: 10.1016/j.bmcl.2011.11.101. Epub 2011 Dec 1. Bioorg Med Chem Lett. 2012. PMID: 22172701
Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.
Guo HZ, Niu LT, Qiang WT, Chen J, Wang J, Yang H, Zhang W, Zhu J, Yu SH. Guo HZ, et al. Among authors: yang h. FASEB J. 2019 Aug;33(8):9565-9576. doi: 10.1096/fj.201900099R. Epub 2019 May 28. FASEB J. 2019. PMID: 31136196
Thus, the inhibition of the IL-17B-IL-17RB axis may be a valid strategy to enhance sensitivity and therapeutic benefit of AML chemotherapy.-Guo, H.-Z., Niu, L.-T., Qiang, W.-T., Chen, J., Wang, J., Yang, H., Zhang, W., Zhu, J., Yu, S.-H. Leukemic IL-17 …
Thus, the inhibition of the IL-17B-IL-17RB axis may be a valid strategy to enhance sensitivity and therapeutic benefit of AML chemotherapy.- …
CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database.
Wang J, Qin D, Ye L, Wan L, Wang F, Yang Y, Ma Y, Yang H, Yang Z, Chen M, Jiang W, Zhang Q. Wang J, et al. Among authors: yang h, yang y, yang z. Aging (Albany NY). 2022 May 12;14(9):4158-4175. doi: 10.18632/aging.204081. Epub 2022 May 12. Aging (Albany NY). 2022. PMID: 35550569 Free PMC article.
60,099 results
You have reached the last available page of results. Please see the User Guide for more information.